购物车
全部删除
您的购物车当前为空
别名 THA-Q, THA Q, PD-139530, PD139530, PD 139530
RLX (PD 139530)是一种 PI3K/Akt/FoxO3a 信号抑制剂,对结肠癌等肿瘤细胞系具有抗癌活性,诱导亚g1阻滞和线粒体潜在损失,抑制肿瘤生长。RLX还具有止咳和抗哮喘的活性,能够减少BAL中嗜酸性粒细胞和总淋巴细胞,对A549细胞具有毒性。

RLX (PD 139530)是一种 PI3K/Akt/FoxO3a 信号抑制剂,对结肠癌等肿瘤细胞系具有抗癌活性,诱导亚g1阻滞和线粒体潜在损失,抑制肿瘤生长。RLX还具有止咳和抗哮喘的活性,能够减少BAL中嗜酸性粒细胞和总淋巴细胞,对A549细胞具有毒性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,980 | 现货 | |
| 5 mg | ¥ 4,920 | 现货 | |
| 10 mg | ¥ 7,130 | 现货 | |
| 25 mg | ¥ 10,600 | 现货 | |
| 50 mg | ¥ 13,800 | 现货 | |
| 100 mg | ¥ 17,500 | 现货 |
RLX 相关产品
| 产品描述 | RLX (PD 139530) is a PI3K/Akt/FoxO3a signal inhibitor with anticancer activity against tumour cell lines such as colon cancer, inducing sub-G1 arrest and mitochondrial potential loss, thereby inhibiting tumour growth. RLX also exhibits antitussive and anti-asthmatic activity, reducing eosinophils and total lymphocytes in bronchoalveolar lavage (BAL) fluid, and exhibits toxicity toward A549 cells. |
| 别名 | THA-Q, THA Q, PD-139530, PD139530, PD 139530 |
| 分子量 | 214.26 |
| 分子式 | C13H14N2O |
| CAS No. | 4425-23-4 |
| Smiles | O=C1C=2C=CC=CC2N=C3N1CCCCC3 |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容